FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2002138955> ?p ?o ?g. }

• W2002138955 endingPage "28" @default.
• W2002138955 startingPage "1" @default.
• W2002138955 abstract "Inflammatory bowel disease (IBD) encompasses several chronic inflammatory disorders leading to the damage of the gastrointestinal tract. The 2 principal forms of these disorders are ulcerative colitis (UC) and Crohn’s disease (CD). Bacteria are involved in the etiology of IBD. Many microorganisms have been put forward as causative factors in IBD, but the primary etiologic agents are still not known. The underlying genetic, environmental, and lifestyle issues can affect the individual’s predisposition to these diseases. Immune factors identified in IBD are: dysregulation of the innate and adaptive immune system directed against luminal bacteria or their products found in the intestinal lumen and inappropriate immune responses to organisms in the intestine that normally do not elicit a response, possibly because of intrinsic alterations in mucosal barrier function. However, recent advances in basic science research revealed new insights into the role of specific immune cells and their mediators in intestinal inflammation. The inflammatory mediators known as “inflammasome” are a consequence of the metabolic products (metabolom) of cells and commensal or pathogenic bacteria. Elucidation of inflammasome and metabolom has led to the development of biomarkers specific for each disease that are involved into management strategies targeted at altering specific pathogenic mechanisms that have the potential to modify or change the natural course of these disease entities. The review discusses the potential role of biomarkers in monitoring the inflammasome and therefore the severity of intestinal damage. The microbial ecosystem in the human gut in different microhabitats and metabolic niches contribute to the bowel metabolome.In addition, this review will focus on our expanding understanding of microbial factors associated with both the initiation and maintenance of IBD. New insights acquired from murine genetic models of inflammatory bowel disease will also be discussed. Inflammatory bowel disease (IBD) encompasses several chronic inflammatory disorders leading to the damage of the gastrointestinal tract. The 2 principal forms of these disorders are ulcerative colitis (UC) and Crohn’s disease (CD). Bacteria are involved in the etiology of IBD. Many microorganisms have been put forward as causative factors in IBD, but the primary etiologic agents are still not known. The underlying genetic, environmental, and lifestyle issues can affect the individual’s predisposition to these diseases. Immune factors identified in IBD are: dysregulation of the innate and adaptive immune system directed against luminal bacteria or their products found in the intestinal lumen and inappropriate immune responses to organisms in the intestine that normally do not elicit a response, possibly because of intrinsic alterations in mucosal barrier function. However, recent advances in basic science research revealed new insights into the role of specific immune cells and their mediators in intestinal inflammation. The inflammatory mediators known as “inflammasome” are a consequence of the metabolic products (metabolom) of cells and commensal or pathogenic bacteria. Elucidation of inflammasome and metabolom has led to the development of biomarkers specific for each disease that are involved into management strategies targeted at altering specific pathogenic mechanisms that have the potential to modify or change the natural course of these disease entities. The review discusses the potential role of biomarkers in monitoring the inflammasome and therefore the severity of intestinal damage. The microbial ecosystem in the human gut in different microhabitats and metabolic niches contribute to the bowel metabolome.In addition, this review will focus on our expanding understanding of microbial factors associated with both the initiation and maintenance of IBD. New insights acquired from murine genetic models of inflammatory bowel disease will also be discussed." @default.
• W2002138955 created "2016-06-24" @default.
• W2002138955 creator A5063785690 @default.
• W2002138955 creator A5090528130 @default.
• W2002138955 date "2012-07-01" @default.
• W2002138955 modified "2023-09-26" @default.
• W2002138955 title "Metabolome and inflammasome in inflammatory bowel disease" @default.
• W2002138955 cites W1607109071 @default.
• W2002138955 cites W1970098628 @default.
• W2002138955 cites W1983372268 @default.
• W2002138955 cites W1983571964 @default.
• W2002138955 cites W1985220113 @default.
• W2002138955 cites W1986876160 @default.
• W2002138955 cites W1990417003 @default.
• W2002138955 cites W1991622904 @default.
• W2002138955 cites W1992446264 @default.
• W2002138955 cites W1992456368 @default.
• W2002138955 cites W1997246021 @default.
• W2002138955 cites W1999411720 @default.
• W2002138955 cites W2000048927 @default.
• W2002138955 cites W2002107602 @default.
• W2002138955 cites W2006632373 @default.
• W2002138955 cites W2008443380 @default.
• W2002138955 cites W2011002068 @default.
• W2002138955 cites W2013826174 @default.
• W2002138955 cites W2016050057 @default.
• W2002138955 cites W2016219300 @default.
• W2002138955 cites W2017410942 @default.
• W2002138955 cites W2020040349 @default.
• W2002138955 cites W2026111800 @default.
• W2002138955 cites W2030421888 @default.
• W2002138955 cites W2033339209 @default.
• W2002138955 cites W2035317748 @default.
• W2002138955 cites W2036125357 @default.
• W2002138955 cites W2040065536 @default.
• W2002138955 cites W2040643627 @default.
• W2002138955 cites W2041269739 @default.
• W2002138955 cites W2043176161 @default.
• W2002138955 cites W2045638397 @default.
• W2002138955 cites W2046234296 @default.
• W2002138955 cites W2049224342 @default.
• W2002138955 cites W2054227231 @default.
• W2002138955 cites W2055976513 @default.
• W2002138955 cites W2057490902 @default.
• W2002138955 cites W2058150509 @default.
• W2002138955 cites W2059542958 @default.
• W2002138955 cites W2061702898 @default.
• W2002138955 cites W2068784177 @default.
• W2002138955 cites W2072513604 @default.
• W2002138955 cites W2076010157 @default.
• W2002138955 cites W2076838997 @default.
• W2002138955 cites W2080574251 @default.
• W2002138955 cites W2083023778 @default.
• W2002138955 cites W2090663439 @default.
• W2002138955 cites W2091941059 @default.
• W2002138955 cites W2094721369 @default.
• W2002138955 cites W2103341578 @default.
• W2002138955 cites W2104414654 @default.
• W2002138955 cites W2105810938 @default.
• W2002138955 cites W2116569898 @default.
• W2002138955 cites W2120371385 @default.
• W2002138955 cites W2123779232 @default.
• W2002138955 cites W2126239641 @default.
• W2002138955 cites W2148237020 @default.
• W2002138955 cites W2149389309 @default.
• W2002138955 cites W2152213080 @default.
• W2002138955 cites W2152972199 @default.
• W2002138955 cites W2213730622 @default.
• W2002138955 cites W25271024 @default.
• W2002138955 cites W2315244913 @default.
• W2002138955 doi "https://doi.org/10.1016/j.trsl.2011.08.006" @default.
• W2002138955 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22687960" @default.
• W2002138955 hasPublicationYear "2012" @default.
• W2002138955 type Work @default.
• W2002138955 sameAs 2002138955 @default.
• W2002138955 citedByCount "30" @default.
• W2002138955 countsByYear W20021389552012 @default.
• W2002138955 countsByYear W20021389552013 @default.
• W2002138955 countsByYear W20021389552014 @default.
• W2002138955 countsByYear W20021389552015 @default.
• W2002138955 countsByYear W20021389552016 @default.
• W2002138955 countsByYear W20021389552017 @default.
• W2002138955 countsByYear W20021389552019 @default.
• W2002138955 countsByYear W20021389552020 @default.
• W2002138955 countsByYear W20021389552021 @default.
• W2002138955 countsByYear W20021389552022 @default.
• W2002138955 countsByYear W20021389552023 @default.
• W2002138955 crossrefType "journal-article" @default.
• W2002138955 hasAuthorship W2002138955A5063785690 @default.
• W2002138955 hasAuthorship W2002138955A5090528130 @default.
• W2002138955 hasConcept C135870905 @default.
• W2002138955 hasConcept C136449434 @default.
• W2002138955 hasConcept C142724271 @default.
• W2002138955 hasConcept C203014093 @default.
• W2002138955 hasConcept C21565614 @default.
• W2002138955 hasConcept C2776914184 @default.
• W2002138955 hasConcept C2777165150 @default.
• W2002138955 hasConcept C2777209026 @default.

• next